Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany

• Hermann Brenner,
• Rafael Cardoso,
• Thomas Heisser,
• Michael Hoffmeister,
• Bernd Holleczek

Affiliations

Hermann Brenner

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, 69120 Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumour Diseases (NCT), INF 460, 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany; Corresponding author. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, 69120 Heidelberg, Germany.

Rafael Cardoso

Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumour Diseases (NCT), INF 460, 69120 Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, INF 672, 69120 Heidelberg, Germany

Thomas Heisser

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, 69120 Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, INF 672, 69120 Heidelberg, Germany

Michael Hoffmeister

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, 69120 Heidelberg, Germany

Bernd Holleczek

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), INF 581, 69120 Heidelberg, Germany; Saarland Cancer Registry, Neugeländstraße 9, 66117 Saarbrücken, Germany